The MYD88L265P mutation, a gain-of-function mutation that leads to constitutive NF-kB activation, is observed in 18–30% of ABC DLBCL and is associated with poor prognosis [14,16,158]. The gene discussed is NFKB1; the disease is aneurysmal bone cyst.